Acacia Research Corporation (Nasdaq:ACTG) announced that a subsidiary has acquired patents relating to infusion pump technology from a major medical device company.
“Acacia is rapidly expanding its presence as a leader in patent licensing for both the technology and medical technology sectors.”
"Acacia continues to increase the number of patent portfolios we control in the medical technology sector," commented Paul Ryan, CEO. "Acacia is rapidly expanding its presence as a leader in patent licensing for both the technology and medical technology sectors."
Revolutionizing diabetes management with reliable blood glucose monitoring without finger pricking